Evidence map›Paper›PMID 32048110›Full record

ArticleEuropean journal of epidemiology2020

Are infectious diseases risk factors for sarcoidosis or a result of reverse causation? Findings from a population-based nested case-control study.

Marios Rossides, Susanna Kullberg, Johan Askling, Anders Eklund, Johan Grunewald, Daniela Di Giuseppe, Elizabeth V Arkema

Open access · hybridAbstract read
In one paragraph

Article in European journal of epidemiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Infectious Complications of Pulmonary Sarcoidosis.Journal of clinical medicine · 2024
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Marios RossidesClinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Eugeniahemmet T2, 171 76, Stockholm, Sweden. marios.rossides@ki.se.ORCID http://orcid.org/0000-0002-9769-324X
Susanna KullbergRespiratory Medicine Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Johan AsklingClinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Eugeniahemmet T2, 171 76, Stockholm, Sweden.ORCID http://orcid.org/0000-0003-0433-0616
Anders EklundRespiratory Medicine Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-7263-7057
Johan GrunewaldRespiratory Medicine Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.ORCID http://orcid.org/0000-0003-0473-3984
Daniela Di GiuseppeClinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Eugeniahemmet T2, 171 76, Stockholm, Sweden.ORCID http://orcid.org/0000-0003-3817-8288
Elizabeth V ArkemaClinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Eugeniahemmet T2, 171 76, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-3677-9736
Karolinska University Hospital · SE

Funding

Karolinska Institutet SFO EpidemiologyVetenskapsrådet 2017-01548
6 · The paper itself

Abstract

Findings from molecular studies suggesting that several infectious agents cause sarcoidosis are intriguing yet conflicting and likely biased due to their cross-sectional design. As done in other inflammatory diseases to overcome this issue, prospectively-collected register data could be used, but reverse causation is a threat when the onset of disease is difficult to establish. We investigated the association between infectious diseases and sarcoidosis to understand if they are etiologically related. We conducted a nested case-control study (2009-2013) using incident sarcoidosis cases from the Swedish National Patient Register (n = 4075) and matched general population controls (n = 40,688). Infectious disease was defined using inpatient/outpatient visits and/or antimicrobial dispensations starting 3 years before diagnosis/matching. Adjusted odds ratios (aOR) of sarcoidosis were estimated using conditional logistic regression and tested for robustness assuming the presence of reverse causation bias. The aOR of sarcoidosis associated with history of infectious disease was 1.19 (95% confidence interval [CI] 1.09, 1.29; 21% vs. 16% exposed cases and controls, respectively). Upper respiratory and ocular infections conferred the highest OR. Findings were similar when we altered the infection definition or varied the infection-sarcoidosis latency period (1-7 years). In bias analyses assuming one in 10 infections occurred because of preclinical sarcoidosis, the observed association was completely attenuated (aOR 1.02; 95% CI 0.90, 1.15). Our findings, likely induced by reverse causation due to preclinical sarcoidosis, do not support the hypothesis that common symptomatic infectious diseases are etiologically linked to sarcoidosis. Caution for reverse causation bias is required when the real disease onset is unknown.

Indexed as

AdultAgedCase-Control StudiesCausalityCommunicable DiseasesCross-Sectional StudiesHumansMiddle AgedPopulation SurveillanceRisk FactorsSarcoidosisSwedenCase–control studyEtiologyInfectionReverse causationSarcoidosis

Identifiers

PMID32048110
PMCPMC7695666
OpenAlexW3006672118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.